0001213900-22-008940.txt : 20220223
0001213900-22-008940.hdr.sgml : 20220223
20220223161207
ACCESSION NUMBER: 0001213900-22-008940
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220218
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Masson-Hurlburt Elizabeth
CENTRAL INDEX KEY: 0001735256
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34673
FILM NUMBER: 22663741
MAIL ADDRESS:
STREET 1: 400 CONNELL DRIVE
STREET 2: SUITE 5000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
FORMER NAME:
FORMER CONFORMED NAME: Masson Elizabeth
DATE OF NAME CHANGE: 20180322
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CorMedix Inc.
CENTRAL INDEX KEY: 0001410098
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-9500
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4
1
doc4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-18
false
0001410098
CorMedix Inc.
CRMD
0001735256
Masson-Hurlburt Elizabeth
C/O CORMEDIX INC.
300 CONNELL DRIVE, SUITE 4200
BERKELEY HEIGHTS
NJ
07922
false
true
false
false
EVP, Head of Clinical Ops.
Common Stock
8000.0000
D
Stock Option (Right to Buy Common Stock)
4.0300
2022-02-18
4
A
false
100000.0000
0.0000
A
2032-02-18
Common Stock
100000.0000
100000.0000
D
Stock Option (Right to Buy Common Stock)
8.3200
2031-01-11
Common Stock
140000.0000
140000.0000
D
Stock Option (Right to Buy Common Stock)
5.6300
2030-05-11
Common Stock
37500.0000
37500.0000
D
Stock Option (Right to Buy Common Stock)
4.0800
2030-05-11
Common Stock
37500.0000
37500.0000
D
Stock Option (Right to Buy Common Stock)
5.6300
2030-02-25
Common Stock
24764.0000
24764.0000
D
Stock Option (Right to Buy Common Stock)
8.3000
2029-01-10
Common Stock
20880.0000
20880.0000
D
Stock Option (Right to Buy Common Stock)
1.4500
2028-03-19
Common Stock
54000.0000
54000.0000
D
These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
These options were granted on 1/10/2019. These options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. These options include options to purchase 2,100 shares that are subject to vesting each on January 10, 2021 and January 10, 2022.
The options vest as follows: 37,200 will vest over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vest on the achievement of certain milestones, subject to continued employment.
These options were granted on 02/18/2022. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.
/s/ Elizabeth Masson-Hurlburt
2022-02-23